If you have been given an outpatient appointment at the hospitals and are unable to attend for whatever reason you can use the form below.
It is really important that you let us know of any changes as soon as possible. This means we can offer the original appointment to another patient.
Please complete the form below with your contact details and as much information as possible. You can find most of the information we need on your appointment letter.
If you have any problems using this form, please call the number on your appointment letter and we will do our best to help you. You will receive a response from us so you know it has been received and actioned.
If you wish to change the date and time of your appointment you, you can click the re-book option and state any dates that are not suitable for you, or you can contact us using the number on your appointment letter.
Rita Arya Principal Investigator
Tel: 01925 662414
Lindsay Roughley Research Midwife
Tel: 01925 275514
A multi-centre double-blind placebo-controlled randomised trial of a combination of methotrexate and gefitinib versus methotrexate and placebo alone as a treatment for ectopic pregnancy with a mechanistic study.
328 participants (164 participants per group) and 30 randomised patients for the mechanistic study (Edinburgh only).
To assess the effectiveness of a combination of methotrexate (MTX) and gefitinib against MTX alone in terms of the need for surgical intervention for ectopic pregnancy.
Trial website: https://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/womens/gem3/index.aspx
CERCLAGE SUTURE TYPE FOR AN INSUFFICIENT CERVIX AND ITS EFFECT ON HEALTH OUTCOMES
For more information, contact the Warrington research midwives or email: CSTICH@trials.bham.ac.uk
or visit https://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/womens/c-stich/index.aspx for more information.
The aim of this study is to develop earlier and safer ways of detecting problems in pregnancy.
Research has shown that it may be possible to use a simple blood test taken from the mother early in pregnancy to gather information about the health of the baby and predict certain complications of pregnancy. This will do this by testing the baby’s genes and other substances in the maternal blood.
PAGE involves a more detailed look at the baby's DNA - capable of picking up smaller changes.
We have taken part in the following studies are currently awaiting the result
PRISMN - Attached is an infographic produced in conjuction eith the Tommy's charity, click the link below to see an animation that summarises the trial findings:
To find out more about them click here.